SYMPTOM BENCHMARKS of IMPROVED QUALITY of LIFE in PTSD

Depression and Anxiety

Volumn 33, Issue 3, 2016, Pages 247-255

  Schnurr, Paula P ^a,b   Lunney, Carole A ^a  

^a NATIONAL CENTER FOR PTSD   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

cognitive behavioral therapy; posttraumatic stress disorder; quality of life; veterans; women

Indexed keywords

ADULT; AGED; ARMY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SELF REPORT; SOCIAL INTERACTION; SOLDIER; SYMPTOM; TREATMENT RESPONSE; VETERAN; IMPLOSIVE THERAPY; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; IMPLOSIVE THERAPY; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; QUALITY OF LIFE; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; YOUNG ADULT;

EID: 84959347797     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22477     Document Type: Article

References (49)

1. Substance Abuse and Mental Health Services Administration. Transforming Mental Health Care in America. The Federal Action Agenda: First Steps. Washington, DC: Department of Health and Human Services; 2005.
2. Gladis MM, Gosch EA, Dishuk NM, et al., Quality of life: expanding the scope of clinical significance. J Consult Clin Psychol 1999; 67: 320-331.
3. Kessler RC, Berglund P, Demler O, et al., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
4. Kessler RC, Petukhova M, Sampson NA, et al., Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012; 21: 169-184.
5. Ramchand R, Schell TL, Karney BR, et al., Disparate prevalence estimates of PTSD among service members who served in Iraq and Afghanistan: possible explanations. J Trauma Stress 2010; 23: 59-68.
6. Wisco BE, Marx BP, Wolf EJ, et al., Posttraumatic stress disorder in the US veteran population: results from the National Health and Resilience in Veterans Study. J Clin Psychiatry 2014; 75: 1338-1346.
7. Mendlowicz MV, Stein MB,. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157: 669-682.
8. Olatunji BO, Cisler JM, Tolin DF,. Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev 2007; 27: 572-581.
9. Schnurr PP, Lunney CA, Bovin MJ, et al., Posttraumatic stress disorder and quality of life: extension of findings to veterans of the wars in Iraq and Afghanistan. Clin Psychol Rev 2009; 29: 727-735.
10. Davidson JRT, Rothbaum BO, Tucker P, et al., Venlafaxine extended release in posttraumatic stress disorder: a sertraline and placebo-controlled study. J Clin Psychopharmacol 2006; 26: 259-267.
11. Ehlers A, Hackmann A, Grey N, et al., A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry 2014; 171: 294-304.
12. Foa EB, Hembree EA, Cahill SP, et al., Randomized trial of prolonged exposure for PTSD with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol 2005; 73: 953-964.
13. Krystal JH, Rosenheck RA, Cramer JA, et al., Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 2011; 306: 493-502.
14. Resick PA, Nishith P, Weaver TL, et al., A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol 2002; 70: 867-879.
15. Schnurr PP, Friedman MJ, Engel CC, et al., Cognitive-behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA 2007; 297: 820-830.
16. Markowitz JC, Petkova E, Neria Y, et al., Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry 2015; 172: 1-11.
17. Monson CM, Macdonald A, Vorstenbosch V, et al., Changes in social adjustment with cognitive processing therapy: effects of treatment and association with PTSD symptom change. J Trauma Stress 2012; 25: 519-526.
18. Schneier FR, Campeas R, Carcamo J, et al., Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety 2015; 32: 570-579.
19. Wachen JS, Jiminez S, Smith K, et al., Long-term functional outcomes of women receiving Cognitive Processing Therapy and Prolonged Exposure. Psychol Trauma 2014; 6 (Suppl 1): S58-S65.
20. Foa EB, Hembree EA, Rothbaum BO,. Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences Therapist Guide. New York, NY: Oxford University Press; 2007.
21. Lunney CA, Schnurr PP,. Domains of quality of life in male veterans treated for PTSD. J Trauma Stress 2007; 20: 955-964.
22. Schnurr PP, Lunney CA,. Work-related outcomes among female veterans and service members after treatment of posttraumatic stress disorder. Psychiatr Serv 2012; 63: 855-861.
23. Schnurr PP, Lunney CA, Forshay E, et al., Sexual function outcomes in women treated for posttraumatic stress disorder. J Women's Health 2009; 18: 1549-1557.
24. Kazdin AE,. The meanings and measurement of clinical significance. J Consult Clin Psychol 1999; 67: 332-339.
25. Kazdin AE,. Almost clinically significant (p <.10): current measures may only approach clinical significance. Clin Psychol Sci Pract 2001; 8: 455-462.
26. Wise EA,. Methods for analyzing psychotherapy outcomes: a review of clinical significance, reliable change, and recommendations for future directions. J Pers Assess 2004; 82: 50-59.
27. Schnurr PP, Friedman MJ, Engel CC, et al., Issues in the design of multisite clinical trials of psychotherapy: CSP #494 as an example. Contemp Clin Trials 2005; 26: 626-636.
28. Weathers FW, Keane TM, Davidson JRT,. Clinician-Administered PTSD Scale: a review of the first ten years of research. Depress Anxiety 2001; 13: 132-156.
29. Weathers FW, Ruscio A, Keane TM,. Psychometric properties of nine scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale. Psychol Assess 1999; 11: 124-133.
30. Spitzer RL, Williams JB, Gibbon M, et al., Structured Clinical Interview for DSM-IV-Patient Version (SCID-P, Version 2.0). Washington, DC: American Psychiatric Press; 1995.
31. Blake DD, Weathers FW, Nagy LM, et al., Clinician-Administered PTSD Scale Instruction Manual. Boston, MA: National Center for Posttraumatic Stress Disorder; 2000.
32. Ware JE, Sherbourne CD,. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
33. Eisen SV, Ranganathan G, Seal P, et al., Measuring clinically meaningful change following mental health treatment. J Behav Health Serv Res 2007; 34: 272-289.
34. Wyrwich K, Tierney W, Wolinsky F,. Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999; 52: 861-873.
35. Frisch MB,. QOLI or Quality of Life Inventory. Minneapolis, MN: Pearson Assessments; 1994.
36. Darlington RB,. Regression and Linear Models. New York, NY: McGraw Hill; 1990.
37. Weathers FW, Marx BP, Friedman MJ, et al., Posttraumatic stress disorder in DSM-5: new criteria, new measures, and implications for assessment. Psychol Inj Law 2014; 7: 93-107.
38. Ehlers A, Grey N, Wild J, et al., Implementation of cognitive therapy for PTSD in routine clinical care: effectiveness and moderators of outcome in a consecutive sample. Behav Res Ther 2013; 51: 742-752.
39. Van Minnen A, Arntz A, Keijsers GPJ,. Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout. Behav Res Ther 2002; 40: 439-457.
40. Bluett EJ, Zoellner LA, Feeny NC,. Does change in distress matter? Mechanisms of change in prolonged exposure for PTSD. J Behav Ther Exp Psychiatry 2014; 45: 97-104.
41. Cloitre M, Stovall-McClough KC, Miranda R, et al., Therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder. J Consult Clin Psychol 2004; 72: 411-416.
42. Laska KM, Smith TL, Wislocki AP, et al., Uniformity of evidence-based treatments in practice? Therapist effects in the delivery of cognitive processing therapy for PTSD. J Couns Psychol 2013; 60: 31-41.
43. Nemeroff CB, Bremner JD, Foa EB, et al., Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res 2006; 40: 1-21.
44. Morina N, Wicherts JM, Lobbrecht J, et al., Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long term outcome studies. Clin Psychol Rev 2014; 34: 249-255.
45. Levitt JT, Malta LS, Martin A, et al., The flexible application of a manualized treatment for PTSD symptoms and functional impairment related to the 9/11 World Trade Center attack. Behav Res Ther 2007; 45: 1419-1433.
46. Galovski TE, Blain LM, Mott JM, et al., Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol 2012; 80: 968-981.
47. Steenkamp M, Litz BT, Hoge CW, et al., Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA 2015; 314: 489-500.
48. Jonas DE, Cusack K, Forneris CA, et al., Psychological and Pharmacological Treatments for Adults with Posttraumatic Stress Disorder (PTSD). AHRQ Publication No. 13-EHC011-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
49. Resick PA, Williams LF, Suvak MK, et al., Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J Consult Clin Psychol 2012; 80: 201-210.